Search Results 181-190 of 17857 for crohns disease

1. Edward V. Loftus, Jr., M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Edward V. Loftus Jr., M.D., is a gastroenterologist studying ulcerative colitis and Crohn's disease.

2. Quality of life for kids with ulcerative colitis and other inflammatory bowel disease - Mayo Clinic

   Children with ulcerative colitis or Crohn's disease are treated at Mayo Clinic's Inflammatory Bowel Disease Center for Children, which provides a ...

3. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease ... Crohn's disease (CD).

4. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

5. Frequent bowel movements Causes - Mayo Clinic

   Antibiotic-associated diarrhea or other problems caused by medicines. Celiac disease · Crohn's disease — which causes tissues in the digestive tract to become ...

6. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) - Mayo Clinic

   A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) ... disease, and previous treatments or health concerns.

7. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease ... Crohn's disease (CD).

8. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

   J Crohns Colitis. 2023 Apr 19; 17 (4):504-512. View PubMed; Guerrero Vinsard ... Crohn's Disease: Results From the SUCCESS Consortium. Am J Gastroenterol ...

9. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

   Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...

10. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...